
About Bioheaven 360
Bioheaven 360 is a Healthcare company based in Delhi (India) founded in 2018. AI-powered genomics tools for disease risk prediction are provided. Bioheaven 360 has raised $264.39 thousand across 3 funding rounds from investors including Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar. Bioheaven 360 was last valued at $1.44 million in June 2022. Its Indian entity Bioheaven 360 Genotec Private Limited reported revenue of βΉ1.86 Cr. Bioheaven 360 offers products and services including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
Bioheaven 360 was established in 2018 in Delhi, India, within the biotechnology sector. AI and machine learning models for patient classification are utilized in clinical environments to enable early detection of osteoporosis. Genomics-based diagnostics tools are offered for disease risk prediction, supporting healthcare applications focused on preventive classification and assessment.
- Headquarters Delhi, India
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website bioheaven360.com
- Social LinkedIn X Facebook
- Legal Name Bioheaven 360 Genotec Private Limited
- Date of Incorporation 27 Mar, 2018
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.86 Cr
FY 2024 · +79% YoY
- Net Profit₹1 Lakh
FY 2024 · 1% margin
- EBITDA₹14 Lakh
FY 2024 · 8% margin
- Total Equity Funding$264.39K (USD)
in 3 rounds
- Latest Funding Round$122.9K (USD), Seed
Jan 2023
- InvestorsDigital Futurists Angels
& 37 more
Associated legal entities of Bioheaven 360
Bioheaven 360 operates through Bioheaven 360 Genotec Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bioheaven 360 Genotec Private Limited CIN U93010DL2018PTC331663 | Active | 27 Mar 2018 | New Delhi, Delhi | ₹1.9 Cr | 3 | View details |
Products & Services of Bioheaven 360
Bioheaven 360 offers a comprehensive portfolio of products and services, including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.
Products for immunology, cell therapies, and biosimilars development.
Alternatives to biological medicines for disease treatment.
AI solutions for industry-specific biological data integration.
Treatments using stem cells for regeneration and health improvement.
Funding Insights of Bioheaven 360
Bioheaven 360 has successfully raised a total of $264.39K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $122.9 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $264,389
- Total Rounds 3
- Last Round Seed β $122,903
- First Round $27,196
(May 2021)
- Investors Count 38
All 3 funding rounds of Bioheaven 360 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $122,903 | Seed | β | Digital Futurists Angels | β |
| Jun 2022 | $114,290 | Angel Round | $1.44M | Christudas Philipose Anchuturuthen, Hiren Thakkar | β |
| May 2021 | $27,196 | Angel Round | $1.65M | Sanjay Nagi, Deepika Gupta Sachdev | β |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2022 | $1.44M | β’β’β’β’β’β’β’β’ |
| May 2021 | $1.65M | β’β’β’β’β’β’β’β’ |
Last known valuation $1.44M (Jun 2022). 38 investors in total: 1 institutional and 37 angel.
Investors in Bioheaven 360
Bioheaven 360 has secured backing from 38 investors, including venture fund and angel investors. Prominent investors backing the company include Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of technology consulting and focused on multiple sectors | 2020 | dfangels.in | Gurugram, India | |
CP Christudas Philipose Anchuturuthen | unknown_d3c361fca1ff442ea | |||
HT Hiren Thakkar | Angel investor and entrepreneur, focused on tech startups in India. | unknown_747f2d114e354d31a | ||
SS Sachin Seth | unknown_6401eac6be6f43b39 | |||
JS Jigar Shah | unknown_bf3b0f84799b4c7c8 | |||
SK Sandeep Kumar Arora | unknown_93c8403b22eb48f79 | |||
SS Shashi Shekhar Mishra | unknown_9a1801be58d5402ab | |||
TD Tushar D Waghulde | unknown_b950e8287e1e4ecdb | |||
RY Rahul Yadav | Founder of Housing.com, angel investor in Indian startups | unknown_9c013dcf76cf404ab | ||
AS Aftab Shamsuddin Mohd | unknown_64e1f473d36148b09 |
Investor details for Bioheaven 360
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bioheaven 360 Genotec Private Limited (Bioheaven 360)
Bioheaven 360 Genotec Private Limited is the primary company behind Bioheaven 360. The board of Bioheaven 360 Genotec Private Limited currently have 3 directors; the longest-serving is Shailendra Vyas, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shailendra Vyas DIN 08097485 | Director | 27 Mar 2018 | 8 yrs 7 mo | Bioheaven 360 Genotec Private Limited |
| Suman Kumari DIN 08097486 | Director | 27 Mar 2018 | 8 yrs 7 mo | Bioheaven 360 Genotec Private Limited |
| Sanjay Nagi DIN 05289153 | Director | 24 Jul 2020 | 6 yrs 3 mo | Bioheaven 360 Genotec Private Limited |
Financials of Bioheaven 360
Figures of Bioheaven 360 Genotec Private Limited, the primary company behind Bioheaven 360, for FY 2024. Revenue was ₹1.86 Cr (+79% year on year). Net profit was ₹1 Lakh (1% margin). EBITDA was ₹14 Lakh (8% margin). Revenue has grown at a compounded annual rate of +91% over three years and +47% over five years.
- ₹1.86 CrRevenue · FY 2024 · +79% YoY
- ₹1 LakhNet profit · 1% margin
- ₹14 LakhEBITDA · 8% margin
- ₹1.1 LakhPaid-up capital
- +91%Revenue CAGR, 3 years
- +47%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bioheaven 360 Genotec Private Limited are on its company page.
Detailed financial statements for Bioheaven 360
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bioheaven 360
4 dated milestones of Bioheaven 360 across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Bioheaven 360 is founded.
- Funding First funding round of $27K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $123K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioheaven 360
Bioheaven 360 was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Bioheaven 360 is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Bioheaven 360 is a funded company, having raised a total of $264.39K across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $27.2K, raised on May 2021.
The primary company behind Bioheaven 360, Bioheaven 360 Genotec Private Limited, reported revenue of βΉ1.86 Cr for FY 2024, up 79% year on year.
Bioheaven 360 was established in 2018 in Delhi, India, within the biotechnology sector. AI and machine learning models for patient classification are utilized in clinical environments to enable early detection of osteoporosis. Genomics-based diagnostics tools are offered for disease risk prediction, supporting healthcare applications focused on preventive classification and assessment.
Bioheaven 360 offers Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.
Bioheaven 360 has 38 investors. Key investors include Digital Futurists Angels, Christudas Philipose Anchuturuthen, Hiren Thakkar, Sachin Seth, and Jigar Shah.
The valuation of Bioheaven 360 is $1.44M as of Jun 2022.
Bioheaven 360 operates through Bioheaven 360 Genotec Private Limited.
The legal entities of Bioheaven 360 currently have 3 directors, including Shailendra Vyas, Sanjay Nagi, Suman Kumari.